title: Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.
authors.affiliation: Vanderbilt University, Nashville, TN, USA.
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Clark
authors.forename: Jennie
authors.initials: J
authors.lastname: Taylor
authors.forename: Daphne L
authors.initials: DL
authors.lastname: Wang
authors.forename: Jeremy S
authors.initials: JS
authors.lastname: Abramson
authors.forename: Tracy T
authors.initials: TT
authors.lastname: Batchelor
mesh_terms: D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005909:Glioblastoma / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide